Experienced in Pseudohypoaldosteronism Type 2

Dr. Aravinda Nanjundappa

Cardiology
9500 Euclid Avenue, 
Cleveland, OH 
On Staff At
Accepting New Patients
Offers Telehealth
Experienced in Pseudohypoaldosteronism Type 2
9500 Euclid Avenue, 
Cleveland, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Aravinda Nanjundappa is a Cardiologist in Cleveland, Ohio. Dr. Nanjundappa is rated as an Experienced provider by MediFind in the treatment of Pseudohypoaldosteronism Type 2. His top areas of expertise are Aortic Valve Stenosis, Peripheral Artery Disease, SVC Obstruction, Transcatheter Aortic Valve Replacement (TAVR), and Angioplasty. Dr. Nanjundappa is currently accepting new patients.

His clinical research consists of co-authoring 89 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Cardiology
Licenses
Internal Medicine in NC
Hospital Affiliations
Cleveland Clinic
Akron General Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Dominion National
  • MEDICARE PDP
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Primetime Health Plan
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE PART D
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
SummaCare
  • HMO
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Cleveland Clinic Main Campus
9500 Euclid Avenue, Cleveland, OH 44195

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Optimize PRO Transcatheter Aortic Valve Replacement Post Market Study
Optimize PRO Transcatheter Aortic Valve Replacement Post Market Study
Enrollment Status: Completed
Publish Date: July 28, 2025
Intervention Type: Device
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial
Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial
Enrollment Status: Active_not_recruiting
Publish Date: June 04, 2025
Intervention Type: Device
Study Phase: Not Applicable
Outcomes of Percutaneous Revascularization for Management of Surgically Ineligible Patients With Multivessel or Left Main Coronary Artery Disease: A Prospective Registry
Outcomes of Percutaneous Revascularization for Management of Surgically Ineligible Patients With Multivessel or Left Main Coronary Artery Disease: A Prospective Registry
Enrollment Status: Active_not_recruiting
Publish Date: May 15, 2025
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension in the Absence of Antihypertensive Medications (SPYRAL PIVOTAL - SPYRAL HTN-OFF MED)
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension in the Absence of Antihypertensive Medications (SPYRAL PIVOTAL - SPYRAL HTN-OFF MED)
Enrollment Status: Completed
Publish Date: March 28, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Randomized Study of the Shockwave Medical Peripheral Lithoplasty® System Used in Combination With DCB Versus Standard Balloon Angioplasty Used in Combination With DCB to Treat Moderate and Severely Calcified Femoropopliteal Arteries
Randomized Study of the Shockwave Medical Peripheral Lithoplasty® System Used in Combination With DCB Versus Standard Balloon Angioplasty Used in Combination With DCB to Treat Moderate and Severely Calcified Femoropopliteal Arteries
Enrollment Status: Completed
Publish Date: December 20, 2023
Intervention Type: Device, Drug
Study Phase: Not Applicable
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
Enrollment Status: Active_not_recruiting
Publish Date: October 06, 2023
Intervention Type: Device
Study Phase: Not Applicable
Prospective, Multicenter, Single-Arm, Global IDE Study of the Shockwave Coronary Intravascular Lithotripsy (IVL) System With the Shockwave C2 Coronary IVL Catheter in Calcified Coronary Arteries
Prospective, Multicenter, Single-Arm, Global IDE Study of the Shockwave Coronary Intravascular Lithotripsy (IVL) System With the Shockwave C2 Coronary IVL Catheter in Calcified Coronary Arteries
Enrollment Status: Completed
Publish Date: May 19, 2023
Intervention Type: Device
Study Phase: Not Applicable
Recombinant tPA by Endovascular Administration for the Treatment of Submassive Pulmonary Embolism Using Pharmaco-mechanical Catheter Directed Thrombolysis for the redUction of Thrombus burdEn
Recombinant tPA by Endovascular Administration for the Treatment of Submassive Pulmonary Embolism Using Pharmaco-mechanical Catheter Directed Thrombolysis for the redUction of Thrombus burdEn
Enrollment Status: Completed
Publish Date: April 20, 2023
Intervention Type: Drug, Device
Study Drug: r-tPA
Study Phase: Phase 3
XIENCE 28 USA Study
XIENCE 28 USA Study
Enrollment Status: Completed
Publish Date: May 03, 2022
Intervention Type: Drug, Device
Study Phase: Not Applicable
A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries(Lutonix BTK Trial)
A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries(Lutonix BTK Trial)
Enrollment Status: Completed
Publish Date: February 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 10 Less Clinical Trials

89 Total Publications

Endovascular management of internal mammary artery injury during laser-assisted transvenous lead extraction: A rare and life-threatening complication.
Endovascular management of internal mammary artery injury during laser-assisted transvenous lead extraction: A rare and life-threatening complication.
Journal: Journal of vascular surgery cases and innovative techniques
Published: August 13, 2025
Similar Doctors
Experienced in Pseudohypoaldosteronism Type 2
Dr. Madonna A. Michael
Cardiology
Experienced in Pseudohypoaldosteronism Type 2
Dr. Madonna A. Michael
Cardiology

University Hospitals Medical Group Inc

11100 Euclid Ave, 
Cleveland, OH 
 (0.9 miles away)
216-844-1000
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients
Offers Telehealth

Madonna Michael is a Cardiologist in Cleveland, Ohio. Dr. Michael is rated as an Advanced provider by MediFind in the treatment of Pseudohypoaldosteronism Type 2. Her top areas of expertise are Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Artery Disease, and Arterial Insufficiency. Dr. Michael is currently accepting new patients.

Experienced in Pseudohypoaldosteronism Type 2
Dr. Heather L. Gornik
Cardiology
Experienced in Pseudohypoaldosteronism Type 2
Dr. Heather L. Gornik
Cardiology

University Hospitals Medical Group Inc

11100 Euclid Ave, 
Cleveland, OH 
 (0.9 miles away)
216-844-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Heather Gornik is a Cardiologist in Cleveland, Ohio. Dr. Gornik is rated as an Elite provider by MediFind in the treatment of Pseudohypoaldosteronism Type 2. Her top areas of expertise are Spontaneous Coronary Artery Dissection (SCAD), Peripheral Artery Disease, Carotid Artery Disease, Angioplasty, and Heart Bypass Surgery. Dr. Gornik is currently accepting new patients.

Experienced in Pseudohypoaldosteronism Type 2
Dr. Anjan N. Gupta
Interventional Cardiology | Cardiology
Experienced in Pseudohypoaldosteronism Type 2
Dr. Anjan N. Gupta
Interventional Cardiology | Cardiology

University Primary Care Practices Inc

158 W Main Rd, 
Conneaut, OH 
 (61.3 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Anjan Gupta is an Interventional Cardiologist and a Cardiologist in Conneaut, Ohio. Dr. Gupta is rated as a Distinguished provider by MediFind in the treatment of Pseudohypoaldosteronism Type 2. His top areas of expertise are Coronary Heart Disease, Angina, Heart Attack, Thrombectomy, and Atherectomy. Dr. Gupta is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nanjundappa's expertise for a condition
ConditionClose
    View All 10 Distinguished Conditions
    View All 22 Advanced Conditions
    View All 72 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile